Orange Book product · Brand (NDA)
METHERGINE
METHYLERGONOVINE MALEATE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
METHYLERGONOVINE MALEATE
Strength
0.2MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 006035
Product number
004
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2021METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 211919 · RISING
- 2020METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 212233 · TP ANDA HOLDINGS
- 2019METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 211455 · TEVA PHARMS USA
- 2018METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 211483 · AMNEAL PHARMS
- 2018METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 210424 · GRANULES
- 2011METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 091577 · CHARTWELL RX
- 2010METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 040889 · BRECKENRIDGE
- 2008METHYLERGONOVINE MALEATEGeneric (ANDA)
ANDA 090193 · AM REGENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
